116 related articles for article (PubMed ID: 23235163)
1. [Therapeutic strategy for gastric cancer with positive peritoneal lavage cytology without peritoneal dissemination].
Iwasaki Y; Ohashi M; Iwanaga T; Oohinata R; Yuu K; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2451-4. PubMed ID: 23235163
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
3. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
4. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
5. [Treatment strategy for patients with CY1 gastric cancer using subgroup analyses].
Nagata H; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2235-8. PubMed ID: 25731481
[TBL] [Abstract][Full Text] [Related]
6. [The treatment strategy for type 4 gastric cancer with positive lavage cytology--a decision making of the therapeutic strategy by the change of the result of the lavage cytology].
Nunobe S; Iwasaki Y; Ohashi M; Shirou I; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1952-4. PubMed ID: 18219862
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of positive cases with peritoneal lavage cytology in gastric cancer].
Yamamoto M; Mashino K; Shibahara K; Oki E; Kakeji Y; Baba H; Maehara Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1389-92. PubMed ID: 16227735
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of peritoneal washing cytology in patients with gastric cancer.
Lee SD; Ryu KW; Eom BW; Lee JH; Kook MC; Kim YW
Br J Surg; 2012 Mar; 99(3):397-403. PubMed ID: 22101572
[TBL] [Abstract][Full Text] [Related]
9. The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients.
Makino T; Fujiwara Y; Takiguchi S; Miyata H; Yamasaki M; Nakajima K; Nishida T; Mori M; Doki Y
Surgery; 2010 Jul; 148(1):96-102. PubMed ID: 20096433
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of peritoneal lavage cytology in gastric cancer].
de Manzoni G; Di Leo A; Tomezzoli A; Pedrazzani C; Piubello Q; Bonfiglio M; Valloncini E; Veraldi GF
Chir Ital; 2002; 54(1):1-6. PubMed ID: 11941998
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences.
La Torre M; Ferri M; Giovagnoli MR; Sforza N; Cosenza G; Giarnieri E; Ziparo V
Eur J Surg Oncol; 2010 Oct; 36(10):982-6. PubMed ID: 20591604
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal cytology in the surgical evaluation of gastric carcinoma.
Hayes N; Wayman J; Wadehra V; Scott DJ; Raimes SA; Griffin SM
Br J Cancer; 1999 Feb; 79(3-4):520-4. PubMed ID: 10027323
[TBL] [Abstract][Full Text] [Related]
13. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
[TBL] [Abstract][Full Text] [Related]
14. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
[TBL] [Abstract][Full Text] [Related]
15. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
16. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer.
Inada T; Ogata Y; Kubota T; Ishihara M; Tomikawa M; Ando J; Ozawa I; Hishinuma S; Shimizu H; Kotake K
Anticancer Res; 2002; 22(1A):291-4. PubMed ID: 12017305
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer.
Kano Y; Kosugi S; Ishikawa T; Otani T; Muneoka Y; Sato Y; Hanyu T; Hirashima K; Bamba T; Wakai T
Surgery; 2015 Dec; 158(6):1581-9. PubMed ID: 25958064
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Yin HR; Lin YZ
J Surg Oncol; 2010 Oct; 102(5):361-5. PubMed ID: 20872942
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
